Godrej Consumer Products Limited

Godrej Consumer Products Limited

GODREJCP.BO
Godrej Consumer Products LimitedIN flagBombay Stock Exchange
1,074.10
INR
-23.40
- -
1.10TMarket Cap
Godrej Consumer Products Limited
GODREJCP.BO
(Bombay Stock Exchange)

Recent

price

1,074.10

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
38.54
49.71
62.68
74.26
80.7
82.36
90.46
95.62
100
96.12
106.96
119.06
129.07
136.63
136.07
- -
142.04
Revenue per Share
5.37
7.45
7.8
7.44
8.88
8.1
12.76
15.99
22.91
14.64
16.83
17.44
16.65
-5.48
18.11
- -
18.12
Basic EPS, GAAP
-12.33
9.65
5.45
9.63
7.97
6.26
16.44
13.82
14.88
14.05
18.25
11.48
18.81
17.24
19.33
- -
- -
Free Cash Flow per Basic Share
1.71
1.5
1.58
1.67
1.75
1.83
1.92
6
12
8
- -
- -
- -
5
25
- -
- -
Dividend per Share
0.34
0.35
0.33
0.33
20.57
26.65
37.46
46.68
55.49
59.59
76.23
93.18
109.51
98.89
91.46
- -
- -
Book Value per Share
-10.41
-4.15
-4.62
-5.86
-12.67
-7.92
-18.02
-9.71
-2.08
-0.76
17.91
36.27
52.72
35.3
27.83
- -
- -
Tangible Book Value per Share
958
976
1,021
1,021
1,021
1,022
1,022
1,022
1,022
1,022
1,022
1,023
1,023
1,023
1,023
- -
1,023
Basic Weighted Avg Shares
36,936
48,509
63,996
75,826
82,422
84,132
92,428
97,722
102,211
98,265
109,360
121,742
131,987
139,741
139,171
151,001
145,322
Sales/Revenue/Turnover
16.33
16.97
14.9
14.71
15.72
18.59
19.29
20.1
19.39
19.99
20.62
18.88
17.59
20.38
19.9
19.13
18.75
Operating Margin (%)
499
644
770
818
908
1,006
1,416
1,557
1,700
1,973
2,038
2,099
2,363
2,410
2,340
2,675
2,439
Depreciation Expense
5,147
7,267
7,961
7,597
9,071
8,276
13,041
16,342
23,415
14,966
17,208
17,834
17,025
-5,606
18,523
18,615
18,540
Net Income, GAAP
21.17
23.13
17.49
20.43
21.81
28.8
22.47
19.85
- -
14.99
17.28
17.25
20.17
382.78
30.67
28.13
29.81
Effective Tax Rate (%)
13.94
14.98
12.44
10.02
11.01
9.84
14.11
16.72
22.91
15.23
15.74
14.65
12.9
-4.01
13.31
12.33
12.76
Profit Margin (%)
-1,576
4,706
5,693
1,183
-907
7,782
10,307
9,928
7,966
2,618
3,367
17,157
25,147
-291
4,044
-6,622
- -
Working Capital
13,420
15,281
18,662
15,908
20,230
24,490
31,082
23,803
26,048
21,792
5,476
4,453
2,467
358
923
2,175
- -
LT Debt
17,252
28,922
35,226
40,005
37,303
42,770
53,020
62,583
72,669
78,984
94,389
115,559
137,942
125,986
120,039
126,530
- -
Total Equity
22.72
15.83
14.51
14.16
15.64
16.32
16.8
16.55
- -
15.11
16.37
15.52
13.19
-52.48
12.06
12.52
- -
Return on Invested Capital (%)
70
42.41
33.91
28.17
23.74
16.86
20.63
21.49
- -
17.45
18.63
17.65
15.18
-9.84
15.69
23.48
11.49
Return on Capital (%)
1,629.37
2,189.25
2,339.41
2,232.2
84.97
34.31
39.82
38.01
44.85
25.45
24.79
20.59
16.43
-5.26
19.03
39.37
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
39,122
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
923
- -
Preferred Equity and Hybrid Capital
- -
47
- -
Shares Outstanding
- -
1,023
- -
Market Capitalization
1,107,259
1,185,015
1,206,012

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
73,379
- -
Cash, Cash Equivalents & STI
- -
35,736
- -
Accounts Receivable, Net
- -
18,191
- -
Inventories
- -
14,186
- -
Total Current Liabilities
- -
69,336
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
39,122
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.01%
6.76%
5.41%
Free Cash Flow
20.65%
5.52%
-2.96%
Net Income, GAAP
-45.87%
-112.75%
0.5%
Sales/Revenue/Turnover
6.13%
6.74%
8.5%
Total Cash Common Dividend
- -
- -
-19.98%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
34,179
35,684
36,228
33,650
139,741
2025
33,108
36,471
37,491
34,941
139,171
2026
36,419
40,795
38,849
- -
151,001

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3.12
4.23
5.68
- -
-5.48
2025
4.41
4.8
4.87
4.03
18.11
2026
4.42
4.87
4.42
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5
2025
- -
- -
- -
- -
25
2026
- -
- -
- -
- -
- -
Business
Godrej Consumer Products Limited (GCPL), an Indian multinational fast-moving consumer goods company headquartered in Mumbai and established in 2001 through the demerger of Godrej Soaps Limited, manufactures and markets a broad portfolio of personal care and household products including soaps such as Godrej No.1, Cinthol, Godrej Fair Glow and Godrej Shikakai; hair colourants such as Godrej Expert, Renew and ColourSoft; toiletries including shaving creams, talcum powders and body washes; liquid detergents such as Ezee, Genteel and Godrej Fab launched in southern India in January 2024; household insecticides under Goodknight and HIT; air fresheners such as aer and Stella; and hygiene products like wet wipes and disinfectants. The company operates in India across 28 states with manufacturing facilities in clusters at Malanpur (Madhya Pradesh), Guwahati (Assam), Baddi (Himachal Pradesh), Pondicherry, Chennai, Tamil Nadu and Sikkim; internationally it serves emerging markets in Asia, Africa, Latin America and the Middle East including Indonesia, South Africa, Nigeria, Kenya and Argentina with additional plants producing personal care and hair products. GCPL targets urban and rural consumers in personal care, home care and hygiene segments through a network of over 650,000 retailers supported by 1,247 distributors, 142 super stockists and 3,175 sub-stockists in India. Recent developments include the acquisition of the Muuchstac men's grooming business encompassing beard care, hair styling and skincare from Trilogy Solutions Private Limited for INR 449 crore in cash completed in November 2025 to bolster its premium personal care portfolio and digital-native presence; a INR 700 crore investment announced in May 2025 to expand manufacturing capacities in Tamil Nadu and Madhya Pradesh in India plus a new facility in Indonesia; an agreement to acquire the FMCG business of Raymond Consumer Care Limited for entry into deodorants and sexual wellness categories; and the integration of the novel Renofluthrin molecule into household insecticides for enhanced efficacy.